Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Cold Chain Distribution

03 Dec 2013 - 04 Dec 2013 - London, UK



Bookmark and Share


SMi Group proudly present Europe’s leading Cold Chain Distribution conference. The 8th annual event will take place on Tuesday 3rd and Wednesday 4th December, 2013, at the Marriott Hotel, Regents Park, London, UK.

Optimisation of the cold chain is imperative for the successful organisation and distribution of a variety of pharmaceutical drugs and products. Continual discussion and development in all aspects of the cold chain is critical for this improvement.

Building on the very successful 2012 event this year’s conference will draw from the expertise of industry specialists, pharmaceuticals, suppliers, and academia. This will provide excellent opportunities for personal and business development, while striking first-class discussion on the fields hottest topics and challenges.

This insightful and informative conference will address cutting edge technology in temperature control management, advances and challenges in transport and logistical methods, the optimisation of distribution efficiency, innovations in packaging and distribution strategies, and many more...

Key reasons to attend:

Discuss key topics with specialists relaying invaluable information of challenges of temperature control, distribution solutions, logistics management, transport methods, regulatory environment, and more

Explore up-to-date innovations and novel strategies to ensure uninterrupted cold chain distribution that ensure minimal costs and maximum results

Maximise your and your company’s cold chain distribution potential by networking with professionals from every level of the industry, pharmaceuticals, suppliers, and academia

New topics for 2013 include: Transportation of dangerous goods by air, Risk evaluation of sea freighting, Comparisons of cold chain monitoring devices, Effective collaboration with vendor companies and more

Receive vital updates on regulation and GDP guidelines and how they will affect your supply chain

Who should attend:

Pharmaceutical companies

Logistics companies

Packaging companies

Regulatory and compliance bodies

Contact: Fateja Begum, Phone: +44 (0) 20 7827 6184, Email: fbegum@smi-online.co.uk



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!